Zarrabi M H, Rosner F
Department of Medicine, Veterans Administration Medical Center, Northport, New York.
Hematol Oncol Clin North Am. 1989 Jun;3(2):303-18.
Aggressive, multimodal treatment of Hodgkin's disease has led to dramatic increases in survival but not without significant early toxicity and late complications. The most serious late complication is the development of a secondary neoplasm. These secondary cancers include acute nonlymphocytic leukemia, non-Hodgkin's lymphoma, and various solid tumors.
对霍奇金淋巴瘤采用积极的多模式治疗已使生存率显著提高,但同时也伴随着明显的早期毒性和晚期并发症。最严重的晚期并发症是继发肿瘤的发生。这些继发性癌症包括急性非淋巴细胞白血病、非霍奇金淋巴瘤和各种实体瘤。